Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial

J Neuroimaging. 2004 Apr;14(2):113-7.

Abstract

Background: Tissue plasminogen activator (TPA) activity may be enhanced with ultrasound, potentially 2 MHz transcranial Doppler (TCD). The authors present Phase I data of the CLOTBUST (Combined Lysis of Thrombus in Brain ischemia using transcranial Ultrasound and Systemic TPA).

Subjects and methods: Nonrandomized stroke patients with proximal arterial occlusion on a prebolus TCD receiving intravenous 0.9 mg/kg TPA within 3 hours after stroke onset were monitored with portable diagnostic TCD equipment and a standard headframe. Complete recanalization was defined as thrombolysis in brain ischemia (TIBI) flow grades 4-5.

Results: 55 patients (mean age 69 +/- 15 years, median baseline NIH Stroke Scale [NIHSS] 18, range 4-29, 90% with 3 9 points) were treated at 125 +/- 36 minutes from symptom onset. TCD monitoring began at 117 +/- 39 minutes. Complete recanalization on TCD within 2 hours after bolus was found in 20 patients (36%). Dramatic recovery (NIHSS score < or = 3) occurred in 20% at 2 hours and in 24% at 24 hours. Overall improvement by > or = 4 NIHSS points was found in 49% at 24 hours. Improvement was associated with recanalization during or shortly after TPA infusion (phi r2 = .5, P = .03); however, in 6/20 patients with complete recanalization (30%), no immediate clinical change was noticed within 2 hours. Overall symptomatic hemorrhage rate was 5.5%.

Conclusions: Continuous TCD insonation for up to 2 hours at maximum intensities allowed by current bio-safety guidelines is safe. Dramatic recovery and complete recanalization shortly after TPA bolus are feasible goals for thrombolysis given with TCD monitoring.

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology
  • Cerebral Arteries / diagnostic imaging
  • Cerebral Arteries / drug effects
  • Cerebral Infarction / diagnostic imaging*
  • Cerebral Infarction / drug therapy*
  • Combined Modality Therapy
  • Equipment Design
  • Female
  • Humans
  • Intracranial Embolism / diagnostic imaging*
  • Intracranial Embolism / drug therapy*
  • Male
  • Middle Aged
  • Neurologic Examination
  • Pilot Projects
  • Point-of-Care Systems*
  • Research Design
  • Technology Assessment, Biomedical
  • Thrombolytic Therapy / instrumentation*
  • Tissue Plasminogen Activator / administration & dosage*
  • Treatment Outcome
  • Ultrasonic Therapy / instrumentation*
  • Ultrasonography, Doppler, Transcranial / instrumentation*

Substances

  • Tissue Plasminogen Activator